Follow
Alexander Vaiserman
Alexander Vaiserman
Head of the Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine
Verified email at geront.kiev.ua
Title
Cited by
Cited by
Year
Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population
A Koliada, G Syzenko, V Moseiko, L Budovska, K Puchkov, V Perederiy, ...
BMC microbiology 17, 1-6, 2017
9162017
Gut microbiota: A player in aging and a target for anti-aging intervention
AM Vaiserman, AK Koliada, F Marotta
Ageing research reviews 35, 36-45, 2017
4122017
Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives
A Vaiserman, D Krasnienkov
Frontiers in Genetics 11, 630186, 2021
2392021
Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues
A Vaiserman, A Koliada, O Zabuga, Y Socol
Dose-Response 16 (3), 1559325818796331, 2018
2162018
Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study
LH Lumey, MD Khalangot, AM Vaiserman
The lancet Diabetes & endocrinology 3 (10), 787-794, 2015
1942015
Epigenetic programming by early‐life stress: Evidence from human populations
AM Vaiserman
Developmental Dynamics 244 (3), 254-265, 2015
1712015
Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: an epigenetic bridge?
A Vaiserman
Aging and disease 5 (6), 419, 2014
1552014
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment
AM Vaiserman
Dose-Response 8 (2), dose-response. 09-037. Vaiserman, 2010
1492010
Nanodelivery of natural antioxidants: An anti-aging perspective
A Vaiserman, A Koliada, A Zayachkivska, O Lushchak
Frontiers in bioengineering and biotechnology 7, 447, 2020
1392020
Anti-aging pharmacology: promises and pitfalls
AM Vaiserman, V Lushchak, AK Koliada
Ageing research reviews 31, 9-35, 2016
1352016
Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population
A Vaiserman, M Romanenko, L Piven, V Moseiko, O Lushchak, ...
BMC microbiology 20, 1-8, 2020
1232020
Hormesis and epigenetics: is there a link?
AM Vaiserman
Ageing research reviews 10 (4), 413-421, 2011
1122011
Metformin as a geroprotector: experimental and clinical evidence
V Piskovatska, N Stefanyshyn, KB Storey, AM Vaiserman, O Lushchak
Biogerontology 20, 33-48, 2019
1092019
Early-life adversity and long-term neurobehavioral outcomes: epigenome as a bridge?
AM Vaiserman, AK Koliada
Human genomics 11, 1-15, 2017
992017
HDAC inhibitors: A new promising drug class in anti-aging research
EG Pasyukova, AM Vaiserman
Mechanisms of ageing and development 166, 6-15, 2017
992017
Early-life nutritional programming of longevity
AM Vaiserman
Journal of developmental origins of health and disease 5 (5), 325-338, 2014
982014
Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?
A Vaiserman
Clinical epigenetics 7, 1-11, 2015
952015
Fucoxanthin and lipid metabolism: A minireview
K Muradian, A Vaiserman, KJ Min, VE Fraifeld
Nutrition, Metabolism and Cardiovascular Diseases 25 (10), 891-897, 2015
942015
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine
AM Vaiserman, B Carstensen, VP Voitenko, MD Tronko, VI Kravchenko, ...
Diabetologia 50, 32-35, 2007
852007
Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity
AM Vaiserman
Dose-Response 8 (1), dose-response. 09-014. Vaiserman, 2010
802010
The system can't perform the operation now. Try again later.
Articles 1–20